Journal of Biochemical and Molecular Toxicology · 2018 · 15 citations · 44 references
Life SciencesOncologyPharmacologyApoptosisCellular MetabolismMetastasisAntioxidant DefenseApoptosis In CancerCancer MetabolismGlutathione MetabolismMalignant NeoplasmsReactive Oxygen SpeciesAnticancer ActivityCatalase FunctionCellular Antioxidant DefenseOxidative Stress In CancerProoxidant EffectsReactive Oxygen Species-induced ApoptosisRedox BalanceSuperoxide Dismutase Function
Anaplastic thyroid carcinoma (ATC) requires more innovative approaches as the current regimes for therapy are inadequate, also most anticancer drugs cause general suppression of physiological functions. However, therapy with limited nontarget tissue damage is desirable. In the present study, we show prooxidant ability of ascorbic acid, which enhances cytotoxicity induced by juglone. We decipher that juglone-ascorbate combination induces reactive oxygen species-mediated apoptosis leading to cell death in ARO cell line originated from ATC. This combination also affects enzyme activity of catalase, glutathione reductase, and superoxide dismutase destabilizing redox balance in cell and thereby making juglone effective at a lower dose. We also show that juglone-ascorbate combination suppresses cell migration, invasion, and expression of tumor-promoting, and angiogenic genes in ARO cell line, thereby disrupting epithelial-mesenchymal transition ability of the cells. Overall, we show that ascorbic acid increases cytotoxic potency of juglone through redox cycling when used in synergy.
44
Qi Chen, Michael Graham Espey, Murali C. Krishna et al. · Proceedings of the National Academy of Sciences · 2005 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +15
Hjördis Thor, Martyn T. Smith, Pia Hartzell et al. · Journal of Biological Chemistry · 1982 · 903 citations · Full text